Solifenacin linked QT interval prolongation and torsades de pointes

Jonathan Bray; Jules Hancox

doi:10.1177/2042098617702616

Solifenacin linked QT interval prolongation and torsades de pointes

Jonathan Bray
, Jules Hancox

Research output: Contribution to journal › Letter (Academic Journal) › peer-review

3 Citations (Scopus)

635 Downloads (Pure)

Abstract

[no abstract]

Original language	English
Number of pages	3
Journal	Therapeutic Advances in Drug Safety
Early online date	10 Apr 2017
DOIs	https://doi.org/10.1177/2042098617702616
Publication status	E-pub ahead of print - 10 Apr 2017

Access to Document

10.1177/2042098617702616

Full-text PDF (accepted author manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Sage at http://journals.sagepub.com/doi/10.1177/2042098617702616. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 489 KB

Handle.net

Persistent link

Cite this

@article{31102f9f30004a9db5d1dc086c9777c8,

title = "Solifenacin linked QT interval prolongation and torsades de pointes",

abstract = "[no abstract]",

author = "Jonathan Bray and Jules Hancox",

year = "2017",

month = apr,

day = "10",

doi = "10.1177/2042098617702616",

language = "English",

journal = "Therapeutic Advances in Drug Safety",

issn = "2042-0986",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Solifenacin linked QT interval prolongation and torsades de pointes

AU - Bray, Jonathan

AU - Hancox, Jules

PY - 2017/4/10

Y1 - 2017/4/10

N2 - [no abstract]

AB - [no abstract]

U2 - 10.1177/2042098617702616

DO - 10.1177/2042098617702616

M3 - Letter (Academic Journal)

C2 - 28845232

SN - 2042-0986

JO - Therapeutic Advances in Drug Safety

JF - Therapeutic Advances in Drug Safety

ER -

Solifenacin linked QT interval prolongation and torsades de pointes

Abstract

Access to Document

Handle.net

Fingerprint

Cite this